Follow
Price Jackson
Price Jackson
Peter MacCallum Cancer Centre
Verified email at petermac.org
Title
Cited by
Cited by
Year
[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
MS Hofman, J Violet, RJ Hicks, J Ferdinandus, SP Thang, T Akhurst, ...
The Lancet Oncology 19 (6), 825-833, 2018
9392018
Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy
WN Rahman, N Bishara, T Ackerly, CF He, P Jackson, C Wong, ...
Nanomedicine in Cancer, 737-752, 2017
4792017
Dosimetry of 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: correlations between pretherapeutic imaging and whole-body tumor dosimetry with treatment outcomes
J Violet, P Jackson, J Ferdinandus, S Sandhu, T Akhurst, A Iravani, ...
Journal of Nuclear Medicine 60 (4), 517-523, 2019
3292019
Long-term follow-up and outcomes of retreatment in an expanded 50-patient single-center phase II prospective trial of 177Lu-PSMA-617 theranostics in metastatic castration …
J Violet, S Sandhu, A Iravani, J Ferdinandus, SP Thang, G Kong, ...
Journal of Nuclear Medicine 61 (6), 857-865, 2020
2382020
Potential dependent superiority of gold nanoparticles in comparison to iodinated contrast agents
PA Jackson, WNWA Rahman, CJ Wong, T Ackerly, M Geso
European journal of radiology 75 (1), 104-109, 2010
1362010
Deep learning renal segmentation for fully automated radiation dose estimation in unsealed source therapy
P Jackson, N Hardcastle, N Dawe, T Kron, MS Hofman, RJ Hicks
Frontiers in oncology 8, 215, 2018
1142018
Fast and low-GPU-memory abdomen CT organ segmentation: the flare challenge
J Ma, Y Zhang, S Gu, X An, Z Wang, C Ge, C Wang, F Zhang, Y Wang, ...
Medical Image Analysis 82, 102616, 2022
1012022
64Cu-SARTATE PET imaging of patients with neuroendocrine tumors demonstrates high tumor uptake and retention, potentially allowing prospective dosimetry for peptide receptor …
RJ Hicks, P Jackson, G Kong, RE Ware, MS Hofman, DA Pattison, ...
Journal of Nuclear Medicine 60 (6), 777-785, 2019
972019
An automated voxelized dosimetry tool for radionuclide therapy based on serial quantitative SPECT/CT imaging
PA Jackson, JM Beauregard, MS Hofman, T Kron, A Hogg, RJ Hicks
Medical physics 40 (11), 112503, 2013
892013
Radiation dosimetry in 177Lu-PSMA-617 therapy using a single posttreatment SPECT/CT scan: a novel methodology to generate time-and tissue-specific dose factors
PA Jackson, MS Hofman, RJ Hicks, M Scalzo, J Violet
Journal of Nuclear Medicine 61 (7), 1030-1036, 2020
882020
Mitogen-activated protein kinase pathway inhibition for redifferentiation of radioiodine refractory differentiated thyroid cancer: an evolving protocol
A Iravani, B Solomon, DA Pattison, P Jackson, A Ravi Kumar, G Kong, ...
Thyroid 29 (11), 1634-1645, 2019
852019
Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose–response relationship
S Siva, P Jackson, T Kron, M Bressel, E Lau, M Hofman, M Shaw, ...
Radiotherapy and Oncology 118 (3), 540-546, 2016
702016
Cold kit for prostate-specific membrane antigen (PSMA) PET imaging: phase 1 study of 68Ga-Tris (Hydroxypyridinone)-PSMA PET/CT in patients with prostate cancer
MS Hofman, P Eu, P Jackson, E Hong, D Binns, A Iravani, D Murphy, ...
Journal of Nuclear Medicine 59 (4), 625-631, 2018
642018
Evaluation of the effects of gold nanoparticle shape and size on contrast enhancement in radiological imaging
P Jackson, S Periasamy, V Bansal, M Geso
Australasian Physical & Engineering Sciences in Medicine 34, 243-249, 2011
552011
Peptide receptor radionuclide therapy with 67Cu-CuSarTATE is highly efficacious against a somatostatin-positive neuroendocrine tumor model
C Cullinane, CM Jeffery, PD Roselt, EM van Dam, S Jackson, K Kuan, ...
Journal of Nuclear Medicine 61 (12), 1800-1805, 2020
502020
Rapid blood clearance and lack of long-term renal toxicity of 177Lu-DOTATATE enables shortening of renoprotective amino acid infusion
R Kashyap, P Jackson, MS Hofman, P Eu, JM Beauregard, D Zannino, ...
European journal of nuclear medicine and molecular imaging 40, 1853-1860, 2013
352013
timeline of radiation-induced kidney function loss after stereotactic ablative body radiotherapy of renal cell carcinoma as evaluated by serial 99mTc-DMSA SPECT/CT
P Jackson, F Foroudi, D Pham, MS Hofman, N Hardcastle, J Callahan, ...
Radiation Oncology 9, 1-4, 2014
342014
Clinical trial protocol for LuTectomy: a single-arm study of the dosimetry, safety, and potential benefit of 177Lu-PSMA-617 prior to prostatectomy
N Dhiantravan, J Violet, R Eapen, O Alghazo, M Scalzo, P Jackson, ...
European urology focus 7 (2), 234-237, 2021
332021
Accuracy and utility of deformable image registration in 68Ga 4D PET/CT assessment of pulmonary perfusion changes during and after lung radiation therapy
N Hardcastle, MS Hofman, RJ Hicks, J Callahan, T Kron, MP MacManus, ...
International Journal of Radiation Oncology* Biology* Physics 93 (1), 196-204, 2015
292015
A deep learning model to automate skeletal muscle area measurement on computed tomography images
KC Amarasinghe, J Lopes, J Beraldo, N Kiss, N Bucknell, S Everitt, ...
Frontiers in Oncology 11, 580806, 2021
282021
The system can't perform the operation now. Try again later.
Articles 1–20